HEARTMATE 3 LVAS IMPLANT KIT
Report
- Report Number
- 2916596-2021-06333
- Event Type
- Death
- Date Received
- November 12, 2021
- Date of Event
- October 19, 2021
- Report Date
- January 6, 2022
- Manufacturer
- THORATEC CORPORATION
- Product Code
- DSQ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
MANUFACTURER INVESTIGATION CONCLUSION: A SPECIFIC CAUSE FOR THE PATIENT'S INFECTION COULD NOT CONCLUSIVELY BE DETERMINED THROUGH THIS EVALUATION. ADDITIONALLY, A DIRECT CORRELATION BETWEEN HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM (LVAS), SERIAL NUMBER (B)(6), AND THE REPORTED EVENT COULD NOT CONCLUSIVELY BE ESTABLISHED THROUGH THIS EVALUATION. THE RELEVANT SECTIONS OF THE DEVICE HISTORY RECORDS FOR (B)(6) WERE REVIEWED AND SHOWED NO DEVIATIONS FROM MANUFACTURING OR QUALITY ASSURANCE SPECIFICATIONS. THE IMPLANT KIT WAS SHIPPED ON 13AUG2020. REVIEW OF THE STERILIZATION AND PACKAGING DOCUMENTATION IN THE DEVICE HISTORY RECORDS FOUND NO DEVIATIONS FROM MANUFACTURING SPECIFICATIONS. THE HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM (LVAS) INSTRUCTION FOR USE (IFU), REV. C, IS CURRENTLY AVAILABLE. SECTION 1 OF THIS DOCUMENT LISTS BLEEDING, INFECTION (LOCALIZED, DRIVELINE, PUMP POCKET OR PSEUDO POCKET), SEPSIS, RENAL DYSFUNCTION, AND DEATH AS ADVERSE EVENTS THAT MAY BE ASSOCIATED WITH THE USE OF HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM. CARE INSTRUCTIONS IN REGARD TO PREVENTING INFECTION ARE PROVIDED IN VARIOUS SECTIONS OF THE IFU, INCLUDING CONTROLLING INFECTION. THE HEARTMATE 3 LVAS PATIENT HANDBOOK, REV. C. IS ALSO CURRENTLY AVAILABLE. THIS DOCUMENT CONTAINS INFORMATION ABOUT PREVENTING INFECTION. REVIEW OF THE STERILIZATION AND PACKAGING DOCUMENTATION IN THE DEVICE HISTORY RECORDS FOUND NO DEVIATIONS FROM MANUFACTURING SPECIFICATIONS. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.
NO FURTHER INFORMATION WAS PROVIDED. A SUPPLEMENTAL REPORT WILL BE SUBMITTED ONCE THE MANUFACTURER¿S INVESTIGATION IS COMPLETED.
IT WAS REPORTED THAT THE PATIENT WITH AN INTERMAC 1 IMPLANT WAS READMITTED WITH STERNAL INFECTION, SEPSIS AND PLEURAL EFFUSION. THE PATIENT UNDERWENT A VIDEO-ASSISTED THORACOSCOPY COMPLICATED BY HEMOTHORAX. THE COURSE WAS COMPLICATED BY CARDIORENAL SYNDROME. REQUIRED HEMODIALYSIS (HD) BUT PATIENT REFUSED LONG TERM HD. HOSPICE CARE WAS INITIATED AND PATIENT EXPIRED ON (B)(6) 2021. THE CAUSE OF DEATH WAS NO RELATED TO LEFT VENTRICULAR ASSIST DEVICE (LVAD). LVAD WILL NOT BE RETURNING FOR ANALYSIS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1702343 | HEARTMATE 3 LVAS IMPLANT KIT | VENTRICULAR (ASSISST) BYPASS | DSQ | THORATEC CORPORATION | 100169571 | 7596393 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Male | Hospitalization| D| L |